16480-57-2

Basic information

• Product Name: sodium 3-phenyl-L-alaninate
• Synonyms: sodium 3-phenyl-L-alaninate;(S)-2-Amino-3-phenylpropionic acid sodium salt;L-Phenylalanine sodium salt;Phenylalanine sodium
• CAS NO: 16480-57-2
• Molecular Formula: C₉H₁₀NO₂*Na
• Molecular Weight: 187.17097
• EINECS: 240-534-3
• Mol File: 16480-57-2.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 307.5°Cat760mmHg
• Flash Point: 139.8°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 0.000313mmHg at 25°C
• CAS DataBase Reference: sodium 3-phenyl-L-alaninate(CAS DataBase Reference)
• NIST Chemistry Reference: sodium 3-phenyl-L-alaninate(16480-57-2)
• EPA Substance Registry System: sodium 3-phenyl-L-alaninate(16480-57-2)

Safety Data

• Hazardous Substances Data: 16480-57-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H11NO2.Na/c10-8(9(11)12)6-7-4-2-1-3-5-7;/h1-5,8H,6,10H2,(H,11,12);/q;+1/p-1/t8-;/m0./s1

Upstream product

• 75428-57-8 N-(1-Methyl-2-ethoxycarbonylvinyl)-DL-phenylalanine sodium salt 
• 35909-92-3 N-carbobenzoxy-L-phenylalanine methyl ester 
• 55740-07-3 (4S)-4-benzyl-5-oxo-1,3-oxazolidine-3-carboxylic acid benzyl ester 
• 63-91-2 L-phenylalanine 

Downstream Products

• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 
• 3588-51-0 N-tert.-Amyloxycarbonyl-phenylalanin 
• 118251-78-8 (+)-<(Z)-N-benzoyl-β-methyldidehydrophenylalanyl>-L-phenylalanine 
• 75428-57-8 N-(1-Methyl-2-ethoxycarbonylvinyl)-DL-phenylalanine sodium salt 
• 92812-93-6 (S)-3-Phenyl-2-(2-pyridin-4-yl-ethoxycarbonylamino)-propionic acid 
• 5002-73-3 ZGlyPheONa 
• 112914-67-7 N-<(S,S)-2,4-dibenzyl-4-carboxybutyryl>-(S)-phenylalanine disodium salt 
• 7535-56-0 N-t-butoxycarbonyl-L-phenylalanine 4-nitrophenyl ester 
• 3086-21-3 Z-Phe-O-Pcp 
• 2578-84-9 N-benzyloxycarbonyl-L-phenylalanine p-nitrophenyl ester 
• 3065-27-8 benzyloxycarbonyl-L-phenylalanine 2,4,5-trichlorophenyl ester 
• 3086-25-7 benzyloxycarbonylphenylalanine 2,4,5-trichlorphenyl ester 
• 1161-13-3 N-Cbz-L-Phe 
• 2577-90-4 methyl (2S)-2-amino-3-phenylpropanoate 

Relevant articles and documents

Bimetallic organotin(IV) complexes with ferrocene-based azomethines: Synthesis, characterization, semi-empirical study, and antibacterial activity

A series of bimetallic organotin(IV) complexes with ferrocene-based azomethines (Schiff bases) were synthesized by reacting sodium salt of tranexamic acid, 4-amino butanoic acid, and phenyl alanine with trimethyltin and tributyltin chloride in 1 : 1 molar ratio under inert atmosphere. The synthesized trialkyl organotin complexes condense with formyl ferrocene under inert atmosphere to yield organotin(IV) ferrocenyl Schiff bases. Composition of the organotin(IV) complexes, bonding behavior of donor groups, and structural assignments were studied by elemental analysis, FT-IR, 1H, 13C, 119Sn NMR, and mass spectrometry. The spectral data suggest that the ligand is bidentate, coordinating through oxygens. Spectroscopic techniques reveal distorted tetrahedral geometry in solution for the complexes. As solids, the complexes are trigonal bipyramidal, confirmed by semi-empirical study. Mass spectrometric and elemental analysis data support the solid and solution spectroscopic results. Bioactivity screenings show invitro biological potential.

Natural amino acid salt catalyzed aldol reactions of isatins with ketones: highly enantioselective construction of 3-alkyl-3-hydroxyindolin-2-ones

Abstract The asymmetric synthesis of 3-alkyl-3-hydroxyindolin-2-ones via direct aldol reaction of isatin with ketones catalyzed by natural amino acid salts is described, in which the phenylalanine lithium salt was found to be the best catalyst. This strategy was then applied to a variety of isatin and ketone substrates and the corresponding aldol products were obtained in excellent yields (up to 97%) with good to excellent enantioselectivities (up to 90%).

NITRIC OXIDE DONATING PROSTAMIDES

Nitroderivatives of prostaglandins having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.